Tenon Medical (NASDAQ:TNON) Upgraded at Wall Street Zen

Posted by on Sep 1st, 2026

Wall Street Zen upgraded shares of Tenon Medical (NASDAQ:TNON – Free Report) to a hold rating in a research note released on Saturday morning,Wall Street Zen reports.

A number of other equities research analysts have also weighed in on TNON. Alliance Global Partners restated a “buy” rating on shares of Tenon Medical in a research note on Wednesday, May 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tenon Medical in a research report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold”.

View Our Latest Analysis on TNON

Tenon Medical Trading Down 9.4%

Shares of TNON opened at $4.53 on Friday. The firm has a market cap of $3.04 million, a PE ratio of -0.10 and a beta of 1.40. Tenon Medical has a 12 month low of $4.38 and a 12 month high of $50.40. The stock has a fifty day moving average price of $7.95 and a 200-day moving average price of $19.51.

Tenon Medical (NASDAQ:TNON – Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($12.35) earnings per share for the quarter, missing the consensus estimate of ($8.40) by ($3.95). Tenon Medical had a negative return on equity of 907.60% and a negative net margin of 257.85%.The business had revenue of $1.28 million for the quarter, compared to analysts’ expectations of $1.54 million.

Hedge Funds Weigh In On Tenon Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. DRW Securities LLC acquired a new stake in Tenon Medical during the 4th quarter worth about $98,000. Geode Capital Management LLC grew its stake in Tenon Medical by 34.6% during the 4th quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock valued at $63,000 after purchasing an additional 17,137 shares during the last quarter. Finally, Jane Street Group LLC acquired a new position in shares of Tenon Medical in the first quarter valued at about $29,000. Hedge funds and other institutional investors own 22.74% of the company’s stock.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.

Read More

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.